3-period full replicates [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2020-07-20 12:04 (1226 d 22:26 ago) – Posting: # 21757
Views: 1,833

Hi Loky do,

❝ I think some countries like ours are very traditional in following guidelines,…


Agree. But the Egyptian GL of 2017 in Section 3.2 recommends the EMA’s approach and not the FDA’s. That’s not a different league but a different sport. For the SAS-codes recommended by the EMA see the Q&A document. Alternatively* you can use Phoenix/WinNonlin, STATISTICA, SPSS, Stata, JPM, or the [image]-pack­age replicateBE.

❝ why using partially replicate design is not favorable nowadays? :confused:


As a starter see this post and that one. I suggest also to search the forum with the keywords lousy and design. Most important reasons:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,811 posts in 4,783 threads, 1,642 registered users;
11 visitors (0 registered, 11 guests [including 6 identified bots]).
Forum time: 09:31 CET (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5